Monday, January 30, 2012

Catalyst Rx details process for generic Lipitor roll-out

While Lipitor became available in generic form on November 30, 2011, the price has not significantly dropped as there is currently only one manufacturer of generic Lipitor.  The new generic Lipitor, atorvastatin, has a total cost only slightly below brand-name Lipitor.

To provide a low net-cost solution to this new expensive generic product Catalyst Rx has engaged the following strategy:
  • Catalyst Rx has contracted directly with the Lipitor manufacturer, Pfizer, for an additional discount at the point-of-sale which will be passed directly to the plan immediately.  This additional discount is almost $50 per 30-day supply.
  • Catalyst Rx is going to block generic Lipitor (atorvastatin) for six months until there are additional manufacturers producing atorvastatin and at that time the price will drop significantly.
  • In the interim, Catalyst is going to move brand-name Lipitor to generic status (Tier 1) so members on brand-name Lipitor will pay the generic copay of the lower costing product.
  • Members currently on Lipitor will be notified via the attached letter which is scheduled to be mailed on November 4th.
  • Once the 6 months manufacturing exclusivity for atorvastatin is over (June 2012) brand-name Lipitor will move to non-preferred status (Tier 3).
One of the exciting aspects of this low net-cost strategy is that there will be no member disruption at all.  Members will not need new prescriptions because our pharmacy partners will be notified as well.  In June of 2012, when the block is removed for atorvastatin, members will automatically move to a generic version that at that time will be produced by multiple generic manufacturers.

No comments:

Post a Comment